NEW YORK, Dec. 9, 2014 /PRNewswire/ -- Levi & Korsinsky
is investigating the Board of Directors of Cubist Pharmaceuticals,
Inc. ("Cubist Pharmaceuticals" or "the Company") (NasdaqGS: CBST)
for possible breaches of fiduciary duty and other violations of
state law in connection with the sale of the Company to Merck &
Co.
Click here to learn more about the investigation:
http://zlk.9nl.com/cubist-pharmaceuticals-cbst.
Under the terms of the transaction, Cubist Pharmaceuticals
shareholders will $102.00 in cash for
each share of Cubist Pharmaceuticals common stock they own. The
investigation concerns whether the Board of Cubist Pharmaceuticals
breached their fiduciary duties to stockholders by failing to
adequately shop the Company before agreeing to enter into this
transaction, and whether Merck & Co. is underpaying for Cubist
Pharmaceuticals shares.
If you own Cubist Pharmaceuticals common stock and wish to
obtain additional information, please contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit
http://zlk.9nl.com/cubist-pharmaceuticals-cbst.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-launches-investigation-of-the-board-of-directors-of-cubist-pharmaceuticals-inc-regarding-the-fairness-of-the-sale-of-the-company-to-merck--co----cbst-300006989.html
SOURCE Levi & Korsinsky, LLP